| Literature DB >> 30852259 |
Chia-Lin Lee1, Chien-Ming Wang2, Hao-Chun Hu3, Hung-Rong Yen4, Ying-Chyi Song5, Sheng-Jie Yu5, Chao-Jung Chen6, Wei-Chu Li7, Yang-Chang Wu8.
Abstract
Qing Dai (Naturalis Indigo) is a traditional Chinese medicine (TCM) used as a topical agent in moderate psoriasis, targeting interleukin-17 (IL-17). In this study, it was prepared from the aerial parts of Strobilanthes cusia. Three undescribed indole alkaloid derivatives, indigodoles A-C, along with seven known compounds were isolated from this preparation of Qing Dai and their structures were elucidated from spectroscopic data, including NMR, MS, UV, IR, optical rotation, and CD. As well, most compounds were tested against IL-17. Indigodole C and tryptanthrin could significantly inhibit IL-17 production of Th17 cells. In addition, indigodole A and indirubin showed notably anti-IL-17 gene expression in dose-dependent effects without cytotoxicities toward Th17 and Jurkat cells, respectively. Overall, our studies indicate that the aforementioned indole alkaloids could contribute to anti-IL 17 properties of Qing Dai.Entities:
Keywords: Anti-IL 17 activities; Indigodoles A–C; Indole alkaloids; Psoriasis; Qing dai (Naturalis indigo); Strobilanthes cusia (Acanthaceae)
Mesh:
Substances:
Year: 2019 PMID: 30852259 DOI: 10.1016/j.phytochem.2019.02.016
Source DB: PubMed Journal: Phytochemistry ISSN: 0031-9422 Impact factor: 4.072